RSS-Feed abonnieren
DOI: 10.1055/s-2005-871266
© Georg Thieme Verlag KG Stuttgart · New York
Myricetin as the Active Principle of Abelmoschus moschatus to Lower Plasma Glucose in Streptozotocin-Induced Diabetic Rats
Publikationsverlauf
Received: August 27, 2004
Accepted: February 22, 2005
Publikationsdatum:
18. Juli 2005 (online)
![](https://www.thieme-connect.de/media/plantamedica/200507/lookinside/thumbnails/10.1055-s-2005-871266-1.jpg)
Abstract
The antihyperglycemic action of myricetin, purified from the aerial part of Abelmoschus moschatus (Malvaceae), was investigated in streptozotocin-induced diabetic rats (STZ-diabetic rats). Bolus intravenous injection of myricetin decreased the plasma glucose concentrations in a dose-dependent manner in STZ-diabetic rats. Myricetin at the effective dose (1.0 mg/kg) significantly attenuated the increase of plasma glucose induced by an intravenous glucose challenge test in normal rats. A stimulatory effect of myricetin on glucose uptake of the soleus muscles isolated from STZ-diabetic rats was obtained in a concentration-dependent manner from 0.01 to 10.0 μmol/L. The increase of glucose utilization by myricetin was further characterized using the enhancement of glycogen synthesis in isolated hepatocytes of STZ-diabetic rats. These results suggest that myricetin has an ability to enhance glucose utilization to lower plasma glucose in diabetic rats lacking insulin.
Key words
Myricetin - Abelmoschus moschatus - Malvaceae - STZ-diabetic rats - glucose uptake - glycogen synthesis
References
- 1 Lopez-Candales A. Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. J Med. 2001; 32 283-300
- 2 Bown D. Encyclopaedia of Herbs and their Uses. Dorling Kindersley London; 1995
- 3 Mira L, Fernandez M T, Santos M, Rocha R, Florencio M H, Jennings K R. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res. 2002; 36 1199-208
- 4 Dajas F, Rivera F, Blasina F, Arredondo F, Echeverry C, Lafon L, Morquio A, Heizen H. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox Res. 2003; 5 425-32
- 5 Ong K C, Khoo H E. Biological effects of myricetin. Gen Pharmacol. 1997; 29 21-6
- 6 Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002; 76 560-8
- 7 Ong K C, Khoo H E. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochem Pharmacol. 1996; 51 423-9
- 8 Geissman T A. The Chemistry of Flavonoids Compounds. Pergamon Press Oxford; 1962: p 419
- 9 Markham K R. Techniques of Flavonoid Identification. Academic Press New York; 1982: p 84
- 10 Nuraliev I uN, Avezov G A. The efficacy of quercetin in alloxan diabetes. Eksp Klin Farmakol. 1992; 55 42-4
- 11 Liu I M, Chi T C, Hsu F L, Chen C F, Cheng J T. Isoferulic acid as active principle from the rhizoma of Cimicifuga dahurica to lower plasma glucose in diabetic rats. Planta Med. 1999; 65 712-4
- 12 Ziel F H, Venkatesan N, Davidson M B. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes. 1988; 37 885-90
- 13 Berger J, Biswas C, Vicario P P, Strout H V, Saperstein R, Pilch P F. Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature. 1989; 340 70-2
- 14 Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J. 1998; 336 1-31
- 15 Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes. 1989; 38 550-7
I-Min Liu, Ph. D.
Department of Pharmacy
Tajen Institute of Technology
Yen-Pou
Ping Tung Shien
Taiwan, R.O.C.
Telefon: +886-7-346-0961
Fax: +886-8-762-5308
eMail: iml@ccsun.tajen.edu.tw